Swedish (OMX) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED May 20, 2026

Discover Swedish Pharmaceuticals & Biotech Growth Stocks that are on the OMX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

92 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MAGLE	SEK 4.20	2.9%	-84.0%	SEK 118.4m	SEK 9.00	0.3	131.3%	n/a
ALZCUR	SEK 1.39	-5.1%	-44.4%	SEK 159.2m	SEK 5.00	14.2	130.4%	n/a
IRLAB A	SEK 1.29	5.4%	-82.1%	SEK 109.4m	SEK 7.50	1.2	130.2%	n/a
GUARD	SEK 1.35	5.8%	-91.2%	SEK 27.3m	SEK 1.75	0.7	119.2%	n/a
ACE	SEK 2.89	-1.4%	-32.1%	SEK 385.9m	SEK 5.60	4.7	104.9%	n/a
VITR	SEK 108.00	2.9%	-31.4%	SEK 14.6b	SEK 162.75	4.3	103.5%	1.0%
ISOFOL	SEK 0.72	3.9%	-40.3%	SEK 229.8m	SEK 3.60	2.1	101.6%	n/a
MOB	SEK 10.96	-0.4%	24.4%	SEK 515.1m	SEK 14.00	35.3	100.9%	n/a
ACTI	SEK 0.072	15.1%	-57.8%	SEK 189.3m	n/a	4.0	98.9%	n/a
BICO	SEK 18.72	4.0%	-46.4%	SEK 1.3b	SEK 31.00	0.8	97.6%	n/a
ONCO	SEK 1.95	10.3%	-3.4%	SEK 771.6m	SEK 2.45	9.3	87.0%	n/a
BIOVIC B	SEK 0.33	-0.9%	-59.9%	SEK 97.2m	n/a	8.9	74.5%	n/a
EGTX	SEK 6.70	-0.7%	108.7%	SEK 3.1b	SEK 9.03	49.0	73.0%	n/a
SYNACT	SEK 14.36	1.0%	-19.9%	SEK 804.2m	SEK 34.65	4.7	64.9%	n/a
DVYSR	SEK 93.00	2.2%	-13.1%	SEK 1.6b	SEK 151.95	104.1	60.3%	n/a
HNSA	SEK 33.58	17.3%	36.9%	SEK 3.4b	SEK 75.00	17.9	51.5%	n/a
SECARE	SEK 26.95	6.9%	-34.3%	SEK 4.3b	SEK 42.00	87.4	50.2%	1.0%
ELIC	SEK 2.95	-5.8%	-42.6%	SEK 143.2m	SEK 7.20	13.5	49.0%	n/a
BINV	SEK 25.80	17.0%	-20.4%	SEK 1.7b	SEK 95.00	7.8	42.2%	n/a
IMMU	SEK 5.76	-3.7%	15.8%	SEK 353.4m	SEK 16.00	0.6	42.1%	n/a
INIT	SEK 2.99	1.4%	-16.9%	SEK 204.7m	SEK 8.03	7.8	35.5%	n/a
CAMX	SEK 536.00	4.3%	1.4%	SEK 32.0b	SEK 770.13	46.9	34.8%	n/a
BONEX	SEK 258.60	7.9%	-8.0%	SEK 17.0b	SEK 377.17	92.0	34.5%	n/a
GENO	SEK 20.05	-4.5%	-21.8%	SEK 1.3b	SEK 32.67	54.5	32.6%	n/a

Page 1 of 4